Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 58 | −12 |
| Shares | 6.04M | 167.3K | 5.76M | −111.2K (−1.9%) |
| Value | $44.8M | $1.24M | $34.1M | −$9.47M (−21.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Brandywine Global Investment Management, LLC | 174,500 | $1.03M | 0.01% |
| UBS Group AG | 12,163 | $72.0K | 0.00% |
| Russell Investments Group, Ltd. | 39 | $231 | 0.00% |
| Nisa Investment Advisors, LLC | 32 | $189 | 0.00% |
Sold out (16)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Two Sigma Advisers, LP | 84,952 | $630.3K |
| ExodusPoint Capital Management, LP | 57,934 | $430.0K |
| Renaissance Technologies LLC | 48,302 | $358.0K |
| Occudo Quantitative Strategies LP | 31,662 | $234.9K |
| Kennedy Capital Management, Inc. | 27,778 | $206.1K |
| Winton Group Ltd | 20,382 | $151.2K |
| Two Sigma Investments, LP | 19,468 | $144.5K |
| Jump Financial, LLC | 16,700 | $123.9K |
| Group One Trading, L.P. | 15,413 | $114.4K |
| Rockefeller Capital Management L.P. | 14,733 | $109.3K |
| Jane Street Group, LLC | 10,585 | $78.5K |
| Squarepoint Ops LLC | 10,285 | $76.3K |
| Quent Capital, LLC | 5,000 | $37.1K |
| GWM Advisors LLC | 300 | $2.23K |
| Trust Co of Vermont | 50 | $371 |
| Coppell Advisory Solutions LLC | 7 | $50 |
Not filed for Q3 2023 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sentinus, LLC | 167,275 | $1.24M |